PTX 8.00% 4.6¢ prescient therapeutics limited

Ann: Prescient Gains IP Rights in CAR-T Collaboration, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,381 Posts.
    lightbulb Created with Sketch. 2045
    CAR-T IP and two other Cancer treatments for a Market Cap of $Aud19 million.

    Might be just a little bit of upside available here (sic). That's just $US12.44 million.



 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.